Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.

about

Antiphospholipid antibodies: laboratory and pathogenetic aspects.Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.

P2860

Q36799474-24300619-3130-4740-A140-B3D532C75F43 Q54589521-6AF0738F-B8E2-4E51-AF3E-31AFB510740E

P2860

Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.

Item

http://www.wikidata.org/entity/Q53947913

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Clinical significance of acqui ...... systemic lupus erythematosus.

@en

Clinical significance of acqui ...... systemic lupus erythematosus.

@nl

type

Item

label

Clinical significance of acqui ...... systemic lupus erythematosus.

@en

Clinical significance of acqui ...... systemic lupus erythematosus.

@nl

prefLabel

Clinical significance of acqui ...... systemic lupus erythematosus.

@en

Clinical significance of acqui ...... systemic lupus erythematosus.

@nl

P1476

Clinical significance of acqui ...... systemic lupus erythematosus.

@en

P2093

A Ordinas

http://www.w3.org/2001/XMLSchema#string

D Tàssies

http://www.w3.org/2001/XMLSchema#string

F Carmona

http://www.w3.org/2001/XMLSchema#string

F J Muñoz-Rodríguez

http://www.w3.org/2001/XMLSchema#string

J Balsch

http://www.w3.org/2001/XMLSchema#string

P2860

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

The 1982 revised criteria for the classification of systemic lupus erythematosus

Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.

Inherited thrombophilia and fetal loss.

Mutation in blood coagulation factor V associated with resistance to activated protein C.

The regulation of hemostasis: the protein C system.

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

P304

730-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/0961203302LU256OA

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joan Carles Reverter Calatayud

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12475003

http://www.w3.org/2001/XMLSchema#string

Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.

about

P2860

P2860

Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698